Equal protection under the law: Children and the Best Pharmaceuticals for Children Act

Four changes to the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act will markedly improve these programmes: expanded attention paid to neonatal studies, support for the off -patent programme, timing and submission of paediatric plans, and the per-manence of the legislation.